ROPES WEALTH ADVISORS LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 145 filers reported holding IMMUNOGEN INC in Q1 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROPES WEALTH ADVISORS LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q4 2020$2,000
+100.0%
2700.0%0.00%
Q3 2020$1,000
-83.3%
270
-70.5%
0.00%
-100.0%
Q4 2017$6,000
-14.3%
9150.0%0.00%0.0%
Q3 2017$7,000915
+15150.0%
0.00%
Q4 2015$06
-88.2%
0.00%
Q3 2015$0510.00%
Other shareholders
IMMUNOGEN INC shareholders Q1 2016
NameSharesValueWeighting ↓
Redmile Group, LLC 13,063,767$35,403,0001.04%
QVT Financial LP 1,375,900$3,442,0000.87%
Virtus ETF Advisers LLC 50,045$136,0000.29%
Fernwood Investment Management, LLC 187,000$507,0000.27%
PURA VIDA INVESTMENTS, LLC 524,600$1,422,0000.20%
Endurant Capital Management LP 184,440$500,0000.20%
Birchview Capital, LP 90,000$244,0000.15%
TWIN FOCUS CAPITAL PARTNERS, LLC 112,873$306,0000.14%
DLD Asset Management, LP 1,239,500$3,347,0000.12%
DLD Asset Management, LP 1,186,300$3,215,0000.12%
View complete list of IMMUNOGEN INC shareholders